{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:31:00Z","timestamp":1787232660227,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara"},{"id":[{"id":"https:\/\/ror.org\/00afdp487","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Heart failure (HF) in patients with conventional right ventricular pacing with significant pacing percentages is still a subject of concern, and management of HF in this population has historically been difficult; however, novel HF pillar medications, such as SGLT2 inhibitors (SGLT2i) and angiotensin receptor\/neprilysin inhibitors (ARNi), have fundamentally transformed contemporary pharmacological HF management. The aim of this study was to assess left ventricular (LV) function after current guideline-directed medical therapy (GDMT) in patients with chronic right ventricular (RV) pacing and HF. Methods: Patients with a lifetime ventricular pacing percentage &gt; 20% (Vp &gt; 20%) and HF diagnosed according to ESC guideline criteria were included. Device interrogation and transthoracic echocardiography (TTE), including assessment of left ventricular ejection fraction (LVEF) and mitral annular plane systolic excursion (MAPSE), were performed at GDMT initiation and during subsequent follow-up. Changes in LVEF and MAPSE were assessed overall and according to baseline HF phenotype. Multivariable linear regression analyses were performed to identify independent predictors of changes in LVEF and MAPSE. Results: Among 550 conventionally paced patients screened for HF, 127 (23.1%) met the inclusion criteria and underwent GDMT initiation. Mean age was 68.2 \u00b1 12.1 years, and mean follow-up duration was 10.2 \u00b1 6.3 months. Baseline LVEF and MAPSE were 48.7 \u00b1 6.3% and 12.0 \u00b1 2.4 mm, respectively. All patients received SGLT2i therapy, while 24 (18.9%) received ARNi. Overall, LVEF increased by 1.94 \u00b1 2.47% and MAPSE by 0.84 \u00b1 0.96 mm (both p &lt; 0.001). Patients with HFrEF (n = 25) showed an increase in LVEF of 5.84 \u00b1 2.53% and MAPSE of 1.72 \u00b1 1.21 mm. In patients with HFmrEF, LVEF increased by 2.50 \u00b1 1.54% and MAPSE by 0.83 \u00b1 0.92 mm, whereas in HFpEF, LVEF increased by 0.67 \u00b1 0.78% and MAPSE by 0.58 \u00b1 0.71 mm. NYHA functional class improved by at least one class in 100 patients (78.7%). In multivariable analysis, ARNi use was independently associated with greater improvement in LVEF and MAPSE, while lower baseline LV function was associated with greater subsequent improvement. Conclusions: In patients with HF and chronic RV pacing, GDMT was associated with modest but statistically significant improvements in LV systolic function, assessed by LVEF and MAPSE, across the HF spectrum. The greatest improvements were observed in patients with HFrEF. However, given the observational design, absence of a control group, and universal use of SGLT2i, these findings do not establish a causal treatment effect or demonstrate superiority of any specific GDMT combination. Prospective controlled studies are warranted to determine the clinical significance of these changes and the independent contribution of individual therapies.<\/jats:p>","DOI":"10.3390\/jcm15166452","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:57:53Z","timestamp":1787230673000},"page":"6452","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Guideline-Directed Medical Therapy on Left Ventricular Function in Heart Failure Patients with Conventional Right Ventricular Pacing"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-5813","authenticated-orcid":false,"given":"Liviu","family":"Cirin","sequence":"first","affiliation":[{"name":"Doctoral School, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Department of Internal Medicine I, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6510-5921","authenticated-orcid":false,"given":"Oana","family":"P\u0103tru","sequence":"additional","affiliation":[{"name":"Doctoral School, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Department of Cardiology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania"},{"name":"Research Center of the Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0859-2498","authenticated-orcid":false,"given":"Silvia","family":"Luca","sequence":"additional","affiliation":[{"name":"Doctoral School, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Department of Cardiology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania"},{"name":"Research Center of the Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Ciubotaru","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7476-6584","authenticated-orcid":false,"given":"Roxana","family":"Buza\u0219","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin-Tudor","family":"Luca","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania"},{"name":"Research Center of the Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lighezan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Center for Advanced Research in Cardiovascular Pathology and Hemostaseology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7378-7787","authenticated-orcid":false,"given":"Drago\u0219","family":"Cozma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania"},{"name":"Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania"},{"name":"Research Center of the Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0972-6292(16)30502-2","article-title":"The downside of right ventricular apical pacing","volume":"12","author":"Brenyo","year":"2012","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Dias-Frias, A., Costa, R., Campinas, A., Alexandre, A., S\u00e1-Couto, D., Sousa, M.J., Roque, C., Vieira, P., Lagarto, V., and Reis, H. (2022). Right ventricular septal versus apical pacing: Long-term incidence of heart failure and survival. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9120444"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cacciapuoti, F., Mauro, C., Caso, I., Crispo, S., Gottilla, R., Capone, V., Ambrosino, S., Pirozzi, C., Munciguerra, O., and Volpicelli, M. (2025). The functional and imaging implications of left bundle branch pacing in ischemic cardiomyopathy. Biomolecules, 15.","DOI":"10.20944\/preprints202502.1117.v1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.21470\/1678-9741-2021-0629","article-title":"Cardiomyopathy induced by artificial cardiac pacing: To whom, when, why, and how? Insights on heart failure development","volume":"38","author":"Ferrari","year":"2023","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e010921196020","DOI":"10.2174\/2772432816666210901111616","article-title":"Pacemaker induced cardiomyopathy: An overview of current literature","volume":"18","author":"Gavaghan","year":"2022","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Malikides, O., Simantirakis, E., Zacharis, E., Fragkiadakis, K., Kochiadakis, G., and Marketou, M. (2024). Cardiac remodeling and ventricular pacing: From genes to mechanics. Genes, 15.","DOI":"10.3390\/genes15060671"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/europace\/euy035","article-title":"Pathobiology of cardiac dyssynchrony and resynchronization therapy","volume":"20","author":"Verzaal","year":"2018","journal-title":"Europace"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kundnani, N.R., Passini, V., Carlogea, I.S., Dumitrescu, P., Meche, V., Buzas, R., and Duda-Seiman, D.M. (2025). Overview of oncology: Drug-induced cardiac toxicity. Medicina, 61.","DOI":"10.3390\/medicina61040709"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Cirin, L., Luca, C.T., V\u0103c\u0103rescu, C., Faur-Grigori, A.A., Ivan, V.S., Dima, C., Buzas, R., Lighezan, D.-F., Cri\u0219an, S., and Cozma, D. (2025). Added value of MAPSE to assess LV systolic function in conventional cardiac pacing. J. Clin. Med., 14.","DOI":"10.3390\/jcm14196880"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lancellotti, P., and Cosyns, B. (2016). The EACVI Echo Handbook, ESC Publications.","DOI":"10.1093\/med\/9780198713623.001.0001"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.19102\/icrm.2018.090501","article-title":"Right ventricular septal pacing: A paradigm shift","volume":"9","author":"Worsnick","year":"2018","journal-title":"J. Innov. Card. Rhythm Manag."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hrthm.2024.05.057","article-title":"Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review","volume":"22","author":"Gerra","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1093\/eurheartj\/ehab364","article-title":"2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy","volume":"42","author":"Glikson","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ejhf.115","article-title":"Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)","volume":"16","author":"McMurray","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro-B-type natriuretic peptide following initiation of sacubitril\/valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"ref_19","first-page":"762","article-title":"A case of pacing-induced cardiomyopathy dramatically reversed by left bundle branch pacing in one week","volume":"7","author":"Yang","year":"2021","journal-title":"Heart Rhythm Case Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40119-023-00346-1","article-title":"Add-on sacubitril\/valsartan therapy induces left ventricular remodeling in nonresponders to cardiac resynchronization therapy to a similar extent as in heart failure patients without resynchronization","volume":"13","author":"Nagy","year":"2024","journal-title":"Cardiol. Ther."},{"key":"ref_21","first-page":"109","article-title":"Impact of sacubitril\/valsartan on systolic heart failure: Right heart location and clustering analysis","volume":"31","author":"Bouali","year":"2022","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Melillo, F., Fabiani, D., Santoro, A., Oro, P., Frecentese, F., Salemme, L., Tesorio, T., Agricola, E., De Bonis, M., and Lorusso, R. (2024). Multimodality imaging for right ventricular function assessment in severe tricuspid regurgitation. J. Clin. Med., 13.","DOI":"10.3390\/jcm13175076"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_24","first-page":"101492","article-title":"Left ventricular reverse remodeling after combined ARNI and SGLT2 therapy in heart failure patients with reduced or mildly reduced ejection fraction","volume":"54","author":"Correale","year":"2024","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12265-023-10389-3","article-title":"Left ventricular systolic function after 3 months of SGLT2 inhibitor therapy in heart failure patients with reduced ejection fraction","volume":"16","author":"Mustapic","year":"2023","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.31083\/j.rcm2504118","article-title":"New insights into pacing induced cardiomyopathy","volume":"25","author":"Kim","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.hroo.2023.01.004","article-title":"The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing-induced cardiomyopathy","volume":"4","author":"Kerley","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"P\u0103tru, O., Luca, S., Cozma, D., V\u0103c\u0103rescu, C., Cri\u0219an, S., Valcovici, M.D., V\u00eertosu, M., Zus, A.S., Luca, C.T., and Dr\u0103gan, S.R. (2025). Cardiac Rehabilitation in the Era of CRT and ARNI: A Missing Link in Heart Failure with Reduced Ejection Fraction Care. J. Clin. Med., 14.","DOI":"10.3390\/jcm14196766"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e003212","DOI":"10.1161\/CIRCHEARTFAILURE.116.003212","article-title":"Effects of sacubitril\/valsartan in the PARADIGM-HF trial according to background therapy","volume":"9","author":"Okumura","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/ejhf.2419","article-title":"Effect of sacubitril\/valsartan on investigator-reported ventricular arrhythmias in PARADIGM-HF","volume":"24","author":"Curtain","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2024.01.027","article-title":"Sacubitril\/valsartan in patients hospitalized with decompensated heart failure","volume":"83","author":"Morrow","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCULATIONAHA.120.051783","article-title":"Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: The EMPEROR-Reduced trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: The EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ciriello, G.D., Altobelli, I., Fusco, F., Colonna, D., Correra, A., Papaccioli, G., and Sarubbi, B. (2024). Sacubitril\/valsartan and dapagliflozin in patients with a failing systemic right ventricle: Effects on the arrhythmic burden. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247659"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wolfes, J., Uphoff, J., Kemena, S., Wegner, F., Rath, B., Eckardt, L., Frommeyer, G., and Ellermann, C. (2024). Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1369250"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"P\u0103tru, O., Luca, S., Cozma, D., V\u0103c\u0103rescu, C., Cri\u0219an, S., Bena, A., V\u00eertosu, M., Zus, A.S., Luca, C.T., and Dr\u0103gan, S.R. (2026). Impact of late ARNI initiation on quality of life and functional capacity in CRT-treated HFrEF patients: A single-centre cohort study. J. Clin. Med., 15.","DOI":"10.3390\/jcm15041617"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"P\u0103tru, O., Luca, S., Cozma, D., V\u0103c\u0103rescu, C., Cri\u0219an, S., Valcovici, M.D., V\u00eertosu, M., Zus, A.S., Luca, C.T., and Dr\u0103gan, S.R. (2025). The role of ARNI in enhancing outcomes of cardiac resynchronization therapy: A comprehensive review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082743"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"oeab046","DOI":"10.1093\/ehjopen\/oeab046","article-title":"Sacubitril\/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: Insights from DISCOVER-ARNI, a multicenter Italian register","volume":"2","author":"Pastore","year":"2022","journal-title":"Eur. Heart J. Open"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1139\/cjpp-2017-0049","article-title":"Risk stratification in patients with heart failure: The value of considering both global longitudinal left ventricular strain and mechanical dispersion","volume":"95","author":"Muntean","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6452\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:11:59Z","timestamp":1787231519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":42,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166452"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166452","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}